Open Access Open Access  Restricted Access Subscription or Fee Access

Prescriptions for opioids and opioid-included polypharmacy: An analysis of the National Hospital Ambulatory Medical Care Survey

Jessica C. Rivera, MD, PhD

Abstract


Objective: Opioid-associated complications are compounded by other concomitant drugs that affect the central nervous system (CNS). This analysis aims to describe opioid and CNS polypharmacy from a representative sample of emergency department (ED) encounters to identify patient- and facility-level characteristics associated with these prescription outcomes.

Design: Generalized linear regression multivariable modeling was used to test for associations between the prescription outcomes and individual and group level predictors.

Setting: Data from the National Hospital Ambulatory Medical Care Survey (NHAMCS) for ED encounters from 2006-2015 were analyzed.

Participants: Survey entrants who received ED care within the above timeframe were analyzed.

Main outcomes: The primary outcomes were dichotomous variables of an opioid or CNS polypharmacy prescription.

Results: Twenty-five percent of encounters resulted in an opioid prescription plus another CNS medication prescription. Diagnoses of a blood disorder, musculoskeletal disorder or gastrointestinal disorder were associated with opioid prescription. Fifty-five percent of the presenting pain level treated with an opioid was reported as severe while 11 percent of opioid prescriptions were given to patients reporting no pain or mild pain. Non-Hispanic blacks had the lowest odds of receiving an opioid or CNS polypharmacy prescription compared to Non-Hispanic whites. Hospitals located within areas of increasing levels of poverty had decreasing odds of dispensing opioids following an ED encounter.

Conclusion: Opioid prescriptions resulted from one-quarter of ED encounters despite the acute care setting of the ED and included 11 percent frequency of prescription for patients reporting no pain or mild pain.


Keywords


opioid prescribing, polypharmacy, acute care, emergency department

Full Text:

PDF

References


Manchikanti L, Boswell MV, Hirsch JA: Lessons learned in the abuse of pain-relief medication: A focus on healthcare costs. Expert Rev Neurother. 2013; 13(5): 527-543.

Guy GP Jr, Zhang K, Bohm MK, et al.: Vital signs: Changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017; 66: 697-704.

Barnett ML, Gray L, Zink A, et al.: Coupling policymaking with evaluation—The opioid crisis. N Engl J Med. 2017; 377: 2306-2309.

Trescot AM, Helm S, Hansen H, et al.: Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pan Physicians (ASIIP) Guidelines. Pain Physician. 2008; 11(2 suppl): 5-62.

Centers for Disease Control and Prevention: CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep. 2016; 65: 1-49.

Frieden TR, Houry D: Reducing the risks of relief—The CDC opioid-prescribing guideline. N Engl J Med. 2016, 374(16): 1501-1504.

Wawrzyniak KM, Sabo A, McDonald A, et al.: Root cause analysis of prescription opioid overdoses. J Opioid Manag. 2015; 11(2): 127-137.

Birnbaum HG, White AG, Schiller M, et al.: Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011; 12(4): 657-667.

Rudd RA, Seth P, David F, et al.: Increases in drug and opioid-involved overdose deaths—United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016; 65: 1445-1452.

Maust DT, Gerlach LB, Gibson A, et al.: Trends in central nervous system-active polypharmacy among older adults seen in out-patient care in the United States. JAMA Intern Med. 2017; 177(4): 583-585.

Turner BJ, Liang Y: Drug overdose in a retrospective cohort with non-cancer pain treated with opioids, antidepressants, and/or sedative-hypnotics: Interactions with mental health disorders. J Gen Intern Med. 2015; 30(8): 1081-1096.

Shah AA, Zogg CK, Zafar SN, et al.: Analgesic access for acute abdominal pain in the emergency department among racial/ethnic minority patients: a nationwide examination. Med Care. 2015; 53(12): 1000-1009.

Kea B, Fu R, Lowe RA, et al.: Interpreting the National Hospital Ambulatory Medical Care Survey: United States emergency department opioid prescribing, 2006-2010. Acad Emer Med. 2016; 23: 159-165.

Paulozzi LJ, Mack KA, Hockenberry JM: Variation among states in prescribing of opioid pain relievers and benzodiazepines—United States, 2012. J Safety Res. 2014; 51: 125-129.

Nottage KA, Hankins JS, Faughnan LG, et al.: Addressing challenges of clinical trials in acute pain: The pain management of vaso-occlusive crisis in children and young adults with sickle cell disease study. Clin Trials. 2016; 13(4): 409-416.

Inoue S, Khan I, Mushtaq R, et al.: Pain management trend of vaso-occlusive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease. Ann Hematol. 2016; 95(2): 221-225.

Bedson J, Chen Y, Ashworth J, et al.: Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: An observational database study. Pain. 2016; 157(7):1525-1531.

Ernst FR, Mills JR, Berner T, et al.: Opioid medication practices observed in chronic pain patients presenting for all-causes to emergency departments: prevalence and impact on health care outcomes. J Manag Care Spec Pharm. 2015; 21(10): 925-936.

Thomas SH, Mumma S, Satterwhite A, et al.: Variation between physicians and midlevel providers in opioid treatment for musculoskeletal pain in the emergency department. J Emerg Med. 2015; 49(4): 415-423.

Gupta S, Patel H, Scopel J, et al.: Impact of constipation on opioid therapy management among long-term opioid users, based on a patient survey. J Opioid Manage. 2015; 11(4): 325-338.

Whitman CB, Reid MW, Arnold C, et al.: Balancing opioid-induced gastrointestinal side effects with pain management: insights from the online community. J Opioid Manag. 2015; 11(5): 393-403.

De Andres J, Fabregat-Cid G, Asensio-Samper JM, et al.: Management of acute pain in patients on treatment with opioids. Pain Manag. 2015; 5(3): 167-173.

Kandasamy R, Price TJ: The pharmacology of nociceptor priming. Hand Exp Pharmacol. 2015; 227:15-37.

Hooten WM, Lamer TJ, Twyner C: Opioid-induced hyperalgesia in community-dwelling adults with chronic pain. Pain. 2015; 156(6): 1145-1152.

Pergolizzi JV Jr, Ma L, Foster DR, et al.: The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients. J Manag Care Spec Pharm. 2014; 20(5): 467-476.

Holt JB: Spatial concentrations and outliers of poverty, United States. 1999. Available at https://www.cdc.gov/dhdsp/maps/gisx/mapgallery/concentrated_poverty.html. Accessed June 1, 2019.

Burgess DJ, van Ryn M, Crowley-Matoka M, et al.: Understanding the provider contribution to race/ethnicity disparities in pain treatment: Insights from dual process models of stereotyping. Pain Med. 2006; 7: 119-134.

Singhal A, Tien YY, Hsia RY: Racial-ethnic disparities in opioid prescriptions at emergency department visits for conditions commonly associated with prescription drug abuse. PLoS One. 2016; 11(8): e0159224.

Santoro TN, Santoro JD: Racial bias and the US opioid epidemic: A review of the history of systemic bias and implications for care. Cureus. 2018; 10(12): e3733.

Sehgal N, Manchikanti L, Smith HS: Prescription opioid abuse in chronic pain: A review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2013; 15(3 suppl): ES67-ES92.

Manchikanti L, Abdi S, Atluri S, et al.: American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2 guidance. Pain Physician. 2012; 15(3 suppl): S67-S116.

Buchman DZ, Ho A, Illes J: You present like a drug addict: Patient and clinician perspectives on trust and trustworthiness in chronic pain management. Pain Med. 2016; 17(8): 1394-1406.

Smith H, Bruckenthal P: Implications of opioid analgesics for medically complicated patients. Drugs Aging. 2010; 27(5): 417-433.

Mularksi RA, White-Chu F, Overbay D, et al.: Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med. 2006; 21(6): 607-612.




DOI: https://doi.org/10.5055/jom.2020.0588

Refbacks

  • There are currently no refbacks.